reports
Bayer AG: 2 directors
Two Directors at Bayer AG bought 6,087 shares at 24.639EUR. The significance rating of the trade was 60/100. Is that information sufficient for you to make an investment decision? This report gives details of those trades and adds context and analysis to them such that you can judge whether these trading decisions are ones worth following. Included in the report is a detailed share price chart which plots discretionary trades by all the company's directors over the last two years clearly showi...
- Carole Braudeau
- Carole Braudeau
- Cedric Rossi
- Clement Genelot
- Loic Morvan
On the shelves now: Consumer Weekly #61
In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week, we look at how Trump's hectic trade policy impacts US consumer sentiment. Happy read
- Clement Genelot
Carrefour: further deterioration in the French franchising crisis
A week after our downgrade to Sell in view of the unsustainable nature of three unsolved French topics (price positioning, franchising crisis, lease-management), the franchising crisis has hit a new stage, with unhappy franchisees launching an initiative to bypass Carrefour for part of their procur
- Research Department
INFORME DIARIO 10 MARZO + RDOS. EUROPA 4T’24. PREVIEWS (ANÁLISIS BANCO...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: CAF, IBERDROLA, INDRA. EUROPA: ALLIANZ, BAYER Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’24 que se publicarán en España y Europa en los próximos días. Las bolsas se mueven entre los aranceles y los planes fiscales Semana cargada de volatilidad tras el repunte histórico de la rentabilidad del bono ale...
- Rafael Bonardell
Informations sur les droits de vote et les actions au 28 février 2025
Informations sur les droits de vote et les actions au 28 février 2025 Le 7 mars 2025 Information mensuelle relative au nombre total de droits de vote et d’actions composant le capital socialArticle 223-16 du Règlement Général de l’Autorité des Marchés Financiers Place de cotation : Euronext ParisCompartiment : Compartiment ACode ISIN : FR0000054470Site web : DateNombre total d’actions composant le capital socialNombre total de droits de voteTotal brut (1)Total net (2)28/02/2025130 796 105143 639 433143 639 433 Le nombre de droits de vote...
GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - févrie...
GROUPE BNP PARIBAS : déclaration mensuelle des droits de vote - février 2025 Raison sociale de l'émetteur :BNP PARIBAS - SA au capital de 2.261.621.342 euros Immatriculée sous le n° 662 042 449 RCS Paris Siège social : 16, boulevard des Italiens, 75009 Paris Informations relatives au nombre total de droits de vote et d'actions prévues parl'article L.233-8 II du code de commerce et l'article 223-16 du règlement général de l'Autorité des Marchés Financiers Date Nombre d'actions composant le capital Nombre total de droits de vote 28 février 20251 130 810 6711 130 810...
- Carole Braudeau
- Emira Sagaama
- Olfa Taamallah
- Thomas Zlowodzki
- Yan Derocles
SREN SWISS RE AG
ADS ADIDAS AG
GFC GECINA SA
LISN CHOCOLADEFABRIKEN LINDT & SPRUENGLI AG
BAYN BAYER AG
01913 PRADA S.P.A.
EVK EVONIK INDUSTRIES AG
INW INFRASTRUTTURE WIRELESS ITALIANE S.P.A.
INX IMCD N.V.
VACN VAT GROUP AG
ABI ANHEUSER-BUSCH INBEV SA/NV
NEOEN NEOEN S.A.
CPR DAVIDE CAMPARI-MILANO N.V.
AM DASSAULT AVIATION
- Emira Sagaama
- Olfa Taamallah
- Thomas Zlowodzki
- Yan Derocles
SREN SWISS RE AG
ADS ADIDAS AG
GFC GECINA SA
LISN CHOCOLADEFABRIKEN LINDT & SPRUENGLI AG
BAYN BAYER AG
01913 PRADA S.P.A.
EVK EVONIK INDUSTRIES AG
INW INFRASTRUTTURE WIRELESS ITALIANE S.P.A.
INX IMCD N.V.
VACN VAT GROUP AG
ABI ANHEUSER-BUSCH INBEV SA/NV
NEOEN NEOEN S.A.
CPR DAVIDE CAMPARI-MILANO N.V.
AM DASSAULT AVIATION
- Carole Braudeau
- Michael B. Schäfer
- Stephan Wulf
- Rafael Bonardell
BAYER: RDOS. 4T’24 (ANÁLISIS BANCO SABADELL)
Rdos. 4T'24 vs 4T'23: Ventas: 11.729 M euros (-1,1% vs -5,4% BS(e) y -4,7% consenso); EBITDA: 2.349 M euros (-22,3% vs -23,7% BS(e) y -25,0% consenso). Rdos. 2024 vs 2023: Ventas: 46.606 M euros (-2,2% vs -3,2% BS(e) y -3,1% consenso); EBITDA: 10.123 M euros (-13,5% vs -13,9% BS(e) y -14,2% consenso).
- Research Department
INFORME DIARIO 05 MARZO + RDOS. EUROPA 4T’24. PREVIEWS (ANÁLISIS BANCO...
COMPAÑÍAS QUE APARECEN EN EL INFORME: ESPAÑA: INDITEX, NATURGY, OHLA, REPSOL. EUROPA: ADIDAS, BAYER. Incluido en el informe diario de hoy, y durante toda la campaña de resultados, incorporamos al final una presentación con los resultados destacados en positivo y negativo y previews de Rdos. 4T’24 que se publicarán en España y Europa en los próximos días. La segunda guerra comercial de Trump se pone en marcha Jornada de aversión al riesgo en las bolsas mundiales y, sobre todo, europeas después ...
- Cedric Rossi
- Clement Genelot
- Loic Morvan
On the shelves now: Consumer Weekly #60
In this Consumer Weekly newsletter, we provide a brief overview of the key factors affecting our Consumer coverage, from Luxury & Consumer goods to Retail & E-commerce and Food & Ingredients. This week, we look at the relative catch-up by European stocks. Happy reading!
- Wedbush Research
XNCR XENCOR INC.
XENE XENON PHARMACEUTICALS INC
VYGR VOYAGER THERAPEUTICS INC.
TTWO TAKE-TWO INTERACTIVE SOFTWARE INC.
SAGE SAGE THERAPEUTICS INC.
RARE ULTRAGENYX PHARMACEUTICAL INC.
O REALTY INCOME CORPORATION
NVCR NOVOCURE LTD.
NBIX NEUROCRINE BIOSCIENCES INC.
MU MICRON TECHNOLOGY INC.
LOW LOWE'S COMPANIES INC.
KURA KURA ONCOLOGY INC.
HD HOME DEPOT INC.
GME GAMESTOP CORP. CLASS A
GERN GERON CORP.
FATE FATE THERAPEUTICS INC
CTMX CYTOMX THERAPEUTICS INC.
CRM SALESFORCE.COM INC.
CMRX CHIMERIX INC
BPMC BLUEPRINT MEDICINES CORP.
BMRN BIOMARIN PHARMACEUTICAL INC.
BIIB BIOGEN INC.
BBY BEST BUY CO. INC.
ASND ASCENDIS PHARMA A/S SPONSORED ADR
ARDX ARDELYX INC
AAP ADVANCE AUTO PARTS INC.
FRX_CN FENNEC PHARMACEUTICALS
7974 NINTENDO CO. LTD.
EA ELECTRONIC ARTS INC.
ANAB ANAPTYSBIO INC.
ARGX ARGENX ADS
MRSN MERSANA THERAPEUTICS
ISR ISORAY
AMD ADVANCED MICRO DEVICES INC.
AAPL APPLE INC.
APLS APELLIS PHARMACEUTICALS
DNLI DENALI THERAPEUTICS INC
RCUS ARCUS BIOSCIENCES
SRRK SCHOLAR ROCK HOLDING CORPORATION
KNSA KINIKSA PHARMACEUTICALS
REPL REPLIMUNE GROUP
EPRT ESSENTIAL PROPERTIES REALTY TRUST
ARVN ARVINAS HOLDING
YMAB Y-MABS THERAPEUTICS
STRO SUTRO BIOPHARMA
STOK STOKE THERAPEUTICS
IGMS IGM BIOSCIENCES
SWTX SPRINGWORKS THERAPEUTICS
IDYA IDEAYA BIOSCIENCES
PASG PASSAGE BIO
BDTX BLACK DIAMOND THERAPEUTICS
ACET ADICET BIO INC
KROS KEROS THERAPEUTICS
ITOS ITEOS THERAPEUTICS
ZNTL ZENTALIS PHARMACEUTICALS
LRMR LARIMAR THERAPEUTICS INC
PRAX PRAXIS PRECISION MEDICINES
U UNITY SOFTWARE
TVTX TRAVERE THERAPEUTICS INC
PLTR PALANTIR TECHNOLOGIES
VRDN VIRIDIAN THERAPEUTICS INC
RBLX ROBLOX
DAWN DAY ONE BIOPHARMACEUTICALS INC
FNMA FEDERAL NATIONAL MORTGAGE ASSOCIATION
ELEV ELEVATION ONCOLOGY
APP APPLOVIN CORP
UWMC UWM HLDGS CORP
ATXS ASTRIA THERAPEUTICS INC
AVTE AEROVATE THERAPEUTICS INC
GMTX GEMINI THERAPEUTICS INC
NTST NETSTREIT CORP
VIGL VIGIL NEUROSCIENCE INC
TYRA TYRA BIOSCIENCES INC
EWTX EDGEWISE THERAPEUTICS INC
DDI DOUBLEDOWN INTERACTIVE CO LTD
APGE APOGEE THERAPEUTICS INC
BNL BROADSTONE NET LEASE INC
- Clement Genelot
Carrefour: No further downside? Look at the dust under the carpet
France has become a house of cards with three unaddressed topics that the market forgot too quickly (overstated price repositioning, unresolved franchising crisis and deteriorating lease-management model). With such a low share price, rising shareholder anger, an ongoing strategic review, mounting
- Carole Braudeau
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.